Organovo Holdings, Inc. (ONVO) Stock: Here’s What’s Happening


Organovo Holdings, Inc. (ONVO) is making a move up in the market today. The company, one that is focused in the biotechnology sector, is currently priced at $0.54 after gaining 12.81% so far in today’s session. In terms of biotechnology companies, there are a number of aspects that have the ability to generate movement in the market. One of the most common is news. Here are the most recent stories surrounding ONVO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-09-19 02:59PM What Kind Of Shareholders Own Organovo Holdings, Inc. (NASDAQ:ONVO)?
Jul-08-19 08:05AM Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
Jun-26-19 06:57AM Investors are still embracing 3-D printing despite some big IPO misfires
Jun-25-19 08:37AM Penny Stocks to Buy Using Technical Analysis for June 2019
Jun-13-19 08:05AM Organovo to Present at Raymond James Life Sciences and MedTech Conference

However, any time investors are making an investing decision, prospective investors should take a look at far more than news, this is especially the case in the speculative biotech sector. Here’s what’s going on with Organovo Holdings, Inc..

The Performance That We’ve Seen From ONVO

While a move toward the top in a single session, like the gain that we’re seeing from Organovo Holdings, Inc. may make some investors jump for joy, a single session gain alone should not be the basis of a decision to, or not to, invest in a company. It is generally a good idea to take a look at trends beyond a single session. When it comes to ONVO, here are the trends that we have seen:

  • Past 5 Trading Sessions – In the past seven days, ONVO has seen a change in price in the amount of 14.89%.
  • Monthly – The monthly returns from Organovo Holdings, Inc. works out to 5.65%.
  • Quarterly – Throughout the past three months, the stock has produced a ROI that works out to -48.08%
  • Bi-Annually – Over the past 6 months, investors have seen a change of -50.91% from the company.
  • Year To Date – Since the the last trading session of last year ONVO has resulted in a return on investment of -43.58%.
  • Annually – Finally, in the past year, investors have seen performance that works out to -61.70% out of ONVO. In this period of time, the stock has sold at a high of -61.97% and a low of 45.91%.

Ratios Worth Paying Attention To

Looking at a few ratios having to do with a company can give prospective traders a look of just how dangerous and/or rewarding a pick might be. Below are some of the important ratios to think about when looking at ONVO.

Short Ratio – The short ratio is a tool that is used by investors to measure the amount of short interest. The higher this short ratio, the more investors have a belief that the stock is headed for declines. Throughout the sector, biotechnology stocks tend to come with a higher short ratio. However, we also see a lot of short squeezes in the sector. Nonetheless, as it relates to Organovo Holdings, Inc., it’s short ratio is 3.72.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Basically, they measure whether or not a company can pay for its debts when they mature with only current assets or quick assets. In the biotech space, many companies are reliant on continued support from investors, these ratios can seem bad. Nonetheless, several better companies in the biotechnology sector come with great quick and current ratios. When it comes to ONVO, the quick and current ratios work out to 10.20 and 10.30 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price of the stock. In this case, that ratio works out to 0.30.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the price of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re interested in a biotech stock, this is a very important ratio to think about. In this case, the cash to share value ratio works out to 0.33.

What Analysts Say About Organovo Holdings, Inc.

While it’s never a smart idea to blindly follow the thoughts of analysts, it is a good idea to consider their thoughts when validating your own opinions before making an investment decision in the biotechnology industry. Here are the most recent moves that we have seen from analysts with regard to ONVO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-13-18 Initiated H.C. Wainwright Buy $2.50
Nov-10-17 Downgrade Raymond James Outperform → Mkt Perform
Jan-25-17 Initiated Raymond James Outperform
Aug-11-15 Downgrade Cantor Fitzgerald Buy → Hold
Jun-29-15 Initiated Piper Jaffray Overweight $5

What Institutions And Insiders Think Of Organovo Holdings, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ONVO, here’s what we’re seeing:

Institutions own 38.50% of the company. Institutional interest has moved by 17.30% over the past three months. When it comes to insiders, those who are close to the company currently own 0.70% percent of ONVO shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

A Look At Share Counts

Traders and investors seem to like to know the counts of shares both outstanding and available. With respect to Organovo Holdings, Inc., currently there are 108.99M with a float of 108.99M. This means that of the total of 108.99M shares of ONVO that are out there today, 108.99M are available to be traded in the public realm.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to ONVO, the short percent of the float is 8.45%.

Financial Results And Expectations

What have ween seen from ONVO in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts have expectations that Organovo Holdings, Inc. will report earnings per diluted share coming to a total of -0.25, with -0.06 being reported in the next financial report. Although this information isn’t based on earnings, because we’re chatting about analysts, ONVO is presently rated a 2.00 when rated on a scale from 1 to 5 on which 1 is the poorest Wall St. analyst rating and 5 is the best.
  • 5-Year Sales – Over the last 5 years, Organovo Holdings, Inc. has generated a movement in sales volume in the amount of 52.20%. EPS over the past 5 years have generated a change of 8.20%.
  • Quarter Over Quarter – when it comes to quarter over quarter data, or Q/Q data as it is generally referred to as in today’s society, ONVO has created a change in earnings that amounts to 13.20%. The company has also experienced a change in terms of revenue that adds up to -36.40%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

As a computer, I am very dependent on humans. A human built me! Although, my builder enabled me to learn by myself, it is a lot simpler to do so when I receive feedback from humans. At the bottom of this article, you will see a comment section. If you’d like for me dig into other information, evolve the way provide data, look at data from a different perspective, or you’re interested in teaching me anything else, I want to hear from you. If you’ve got something to offer consider leaving a comment below. I’ll process that comment and it will help me evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here